Wave Life Valuation
| WVE Stock | USD 10.99 0.32 2.83% |
At this time, the company appears to be overvalued. Wave Life Sciences maintains a prevalent Real Value of $10.38 per share. The last-minute price of the company is $10.99. Our model calculates the value of Wave Life Sciences from examining the company fundamentals such as Return On Asset of -0.34, current valuation of 1.44 B, and Profit Margin of (2.66) % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Wave Life's price fluctuation is somewhat reliable at this time. Calculation of the real value of Wave Life Sciences is based on 3 months time horizon. Increasing Wave Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Wave stock is determined by what a typical buyer is willing to pay for full or partial control of Wave Life Sciences. Since Wave Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Wave Stock. However, Wave Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.99 | Real 10.38 | Hype 10.99 |
The real value of Wave Stock, also known as its intrinsic value, is the underlying worth of Wave Life Sciences Company, which is reflected in its stock price. It is based on Wave Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Wave Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Wave Life Sciences helps investors to forecast how Wave stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Wave Life more accurately as focusing exclusively on Wave Life's fundamentals will not take into account other important factors: Wave Life Total Value Analysis
Wave Life Sciences is at this time anticipated to have company total value of 1.44 B with market capitalization of 1.73 B, debt of 32.12 M, and cash on hands of 148.16 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Wave Life fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.44 B | 1.73 B | 32.12 M | 148.16 M |
Wave Life Investor Information
About 15.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 1.12. Wave Life Sciences had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Wave Life's historical financial statements, Wave Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Wave Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Wave Life has an asset utilization ratio of 41.21 percent. This indicates that the Company is making $0.41 for each dollar of assets. An increasing asset utilization means that Wave Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Wave Life Ownership Allocation
Wave Life Sciences retains a total of 152.52 Million outstanding shares. The majority of Wave Life outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Wave Life Sciences to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Wave Life Sciences. Please pay attention to any change in the institutional holdings of Wave Life Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Wave Life Profitability Analysis
The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (95.5 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Wave Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Wave Life and how it compares across the competition.
About Wave Life Valuation
The stock valuation mechanism determines Wave Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Wave Life. We calculate exposure to Wave Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Wave Life's related companies.Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people.
Wave Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Wave Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 106.1 M |
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |